Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

NCT00348608 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision (due to low subject recruitment)

Conditions

Coronary Artery Disease

Interventions

DRUG: iodixanol

Sponsor

GE Healthcare